Sialic Acids and Sialoglycoconjugates in the Biology of Life, Health and Disease 2020
DOI: 10.1016/b978-0-12-816126-5.00011-1
|View full text |Cite
|
Sign up to set email alerts
|

Nanotechnology and sialic acid biology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3
1
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 127 publications
(129 reference statements)
0
4
0
Order By: Relevance
“…pPS-NPs bind to the anionic headgroup of phospholipids or other negatively charged molecules such as sialic acids in membrane proteins . The sialic acid moiety is abundantly expressed in human alveolar cells and serves as the docking site for the viral entry . In comparison to nPS-NPs, the larger electrostatic interactions of pPS-NPs resulted in their more effective internalization followed by the increase in intracellular ROS levels.…”
Section: Discussionmentioning
confidence: 99%
“…pPS-NPs bind to the anionic headgroup of phospholipids or other negatively charged molecules such as sialic acids in membrane proteins . The sialic acid moiety is abundantly expressed in human alveolar cells and serves as the docking site for the viral entry . In comparison to nPS-NPs, the larger electrostatic interactions of pPS-NPs resulted in their more effective internalization followed by the increase in intracellular ROS levels.…”
Section: Discussionmentioning
confidence: 99%
“…[86][87][88][89][90][91][92][93] Many different scaffolds have been used to chemically attach sialic acid, including antibodies, DNA, fullerenes, graphene, polyacrylamide, quantum dots, magnets, silver and gold nanoparticles, although biocompatibility and potential toxicological liabilities of all of these remain and none have progressed to approval for use in humans. 76,94 Controlling the spatial distribution and number of ligand-bearing units in these oligomers can also be sub-optimal and/or ill-defined, leading to reduced binding or promiscuous binding to other sialic acid receptors (Table 1). The lack of target specificity can lead to faster in vivo clearance rates and may also explain reported toxicities for many polymeric inhibitors.…”
Section: Sialic Acid Receptors Of Virusesmentioning
confidence: 99%
“…A promising alternative is the use of multivalent display of mimetics onto a nanoparticles, liposomes or polymers [ 96 ] ( Figure 7 ). Bio-orthogonal synthesis is enabling the presentation of modified sialic acids on nanoparticles, polymers, and living cells [ 97 , 98 ].…”
Section: Modified Sialic Acids Targeting Siglecsmentioning
confidence: 99%